Intriguingly, the potential roles of insulin in the pathogenesis and treatment of some neurological diseases, including depression, cognitive decline, and Alzheimer's disease (AD), have expanded the brain insulin signaling research field beyond the confines of diabetes. This evidence concerns the gene INS and depressive symptom measurement.